Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Länsförsäkringar Skånes Fastighets AB
Mandate

Vinge advises Länsförsäkringar Skånes Fastighets AB

December 19, 2017

Vinge has advised Länsförsäkringar Skånes Fastighets AB in conjunction with its acquisition of three new residential areas and a car park from Skanska.

There will be approximately 300 residential leases as well as a car park with approximately 480 parking spaces and 160 outdoor parking spaces which will be built in Limhamns Sjöstad, Malmö. The transaction is conditional upon the grant of planning permission. Commencement of the construction is planned for the second quarter of 2018 and the project is expected to be completed in phases.

Vinge’s team consisted of partner Henrik Ossborn together with, among others, associates Jessica Salomonsson and Rebecka Maltenius and specialist Mathias Lindquist.

Related

Vinge advises Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun

 Vinge is advising Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun from Dalafast. The acquisition comprises four properties with a total of 23,200 square metres of retail space, which together constitute Tallen’s largest retail area.
November 11, 2026

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

 On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026